Abstract B67: Synthetic DNA Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T Cell-Mediated Effector Immunity Impacting Tumor Challenge
Cancer immunology research（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined